CLARIVIB 250CLARITHROMYCIN 250mg. IP

Clarivib 250 tablets contain clarithromycin 250 mg and are used for mild to moderate infections caused by susceptible bacteria. Main uses: mild to moderate acute bacterial exacerbation of chronic bronchitis in adults; mild to moderate acute maxillary sinusitis; community-acquired pneumonia; pharyngitis and tonsillitis; uncomplicated skin and skin structure infections.

Common side effects of Clarivib 250 Tablet include abdominal pain; diarrhoea; nausea; vomiting; altered taste (dysgeusia); indigestion (dyspepsia). Get medical help at once if you notice severe acute hypersensitivity reactions; QT prolongation and ventricular arrhythmia (torsades de pointes); hepatotoxicity (liver inflammation, jaundice).

Each Clarivib 250 tablet contains Clarithromycin 250 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Clarivib 250 Tablet only as your doctor advises.

The MRP of Clarivib 250 Tablet is ₹189 for a pack of 10x10 (Blister). For chemists and distributors, the PTR is ₹144 and the PTS is ₹129.6.

Each Clarivib 250 tablet contains Clarithromycin 250 mg. It comes in a pack of 10x10 (Blister).

The medicine in Clarivib 250 works by stopping the growth of the bacteria that are responsible for the infection. By bringing the number of bacteria under control, it allows the body to clear the infection and the related symptoms to settle. It acts against susceptible bacteria only, so it is used when the infection is proven or strongly suspected to be bacterial.

Must not be used by patients allergic to clarithromycin, erythromycin or any other macrolide drug. Must not be used with cisapride, pimozide, lurasidone, lomitapide, lovastatin, simvastatin or ergot alkaloids (ergotamine, dihydroergotamine). Must not be used with colchicine in patients with renal or hepatic impairment, or by patients who previously had cholestatic jaundice or liver dysfunction caused by clarithromycin. Should be avoided in patients with known QT prolongation, ventricular arrhythmia (torsades de pointes), low potassium or magnesium, significant bradycardia, or those taking Class IA or III antiarrhythmics or other drugs known to prolong the QT interval. Check with a doctor first if you have myasthenia gravis, liver problems or coronary artery disease, or if you are pregnant.

Clarivib 250 Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.